Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | CRAT | P43155 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | ACACB | O00763 | 2/20 | 0.34 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2140805 | 0.91 | TSHR (0.54) | TSHRCRATCHRM2CHRM4CHRM1 | |
| SCHEMBL6116476 | 0.91 | TSHR (0.41) | TSHRCRATTGM2CHRM2CHRM4 | |
| Water SCHEMBL31228205 | 0.90 | TSHR (0.52) | TSHRCRATCHRM2CHRM4CHRM1 | |
| Hydrochloric Acid SCHEMBL1483412 | 0.90 | TSHR (0.52) | TSHRCRATCHRM2CHRM4CHRM1 | |
| Sulfuric Acid SCHEMBL31228311 | 0.81 | TSHR (0.39) | TSHRCRATTGM2CPT2CPT1A | |
| Sulfuric Acid SCHEMBL10551555 | 0.79 | TSHR (0.48) | TSHRTGM2ACACBSMN1; SMN2ALDH1A1 | |
| Potassium Ion SCHEMBL9616732 | 0.76 | TSHR (0.48) | TSHRTGM2ACACBALDH1A1MAPK1 | |
| SCHEMBL3685622 | 0.76 | TSHR (0.48) | TSHRTGM2ACACBALDH1A1MAPK1 | |
| SCHEMBL9788021 | 0.75 | POLB (0.38) | BLMALDH1A1MEN1KMT2ALMNA | |
| Bromide SCHEMBL6117220 | 0.75 | TSHR (0.47) | TSHRACACBALDH1A1MAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618000-B2 | Friction reduction of acidic treatment fluids | HALLIBURTON ENERGY SERVICES, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260071533-A1 | TREATMENT FLUID SELECTION | HALLIBURTON ENERGY SERVICES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-12247165-B2 | Anti-syneresis agents for fracturing operations | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-03-11 | — | — | US | disclosed |
| US-20250075122-A1 | ADDITIVES TO PREVENT THERMAL THINNING IN POLYMER GEL SYSTEMS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-03-06 | — | — | US | disclosed |
| US-20250051634-A1 | ANTI-SYNERESIS AGENTS FOR FRACTURING OPERATIONS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-02-13 | — | — | US | disclosed |
| US-20250051635-A1 | FRICTION REDUCTION OF ACIDIC TREATMENT FLUIDS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-02-13 | — | — | US | disclosed |
| WO-2025006003-A1 | FRICTION REDUCTION OF ACIDIC TREATMENT FLUIDS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-01-02 | — | — | WO | disclosed |
| US-12139667-B1 | Friction reduction of acidic treatment fluids | HALLIBURTON ENERGY SERVICES, INC. (US) | 2024-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071533-A1 | TREATMENT FLUID SELECTION | PLG, SOST, CSTB | TSHR 1255/4885CRAT 654/4885TGM2 3285/4885 |
| US-12618000-B2 | Friction reduction of acidic treatment fluids | GFER, FGB, NSF | TSHR 1564/4885CRAT 3472/4885TGM2 3250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.